959163-01-0

Basic information

• Product Name: 6-chloro-4-(ethylamino)-3-Pyridinecarboxaldehyde
• Synonyms: 6-chloro-4-(ethylamino)-3-Pyridinecarboxaldehyde;6-chloro-4-(ethylamino)nicotinaldehyde
• CAS NO: 959163-01-0
• Molecular Formula: C₈H₉ClN₂O
• Molecular Weight: 184.62286
• Mol File: 959163-01-0.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 347.4±42.0 °C(Predicted)
• Appearance: /
• Density: 1.297±0.06 g/cm3(Predicted)
• PKA: 1.09±0.10(Predicted)
• CAS DataBase Reference: 6-chloro-4-(ethylamino)-3-Pyridinecarboxaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 6-chloro-4-(ethylamino)-3-Pyridinecarboxaldehyde(959163-01-0)
• EPA Substance Registry System: 6-chloro-4-(ethylamino)-3-Pyridinecarboxaldehyde(959163-01-0)

Safety Data

• Hazardous Substances Data: 959163-01-0(Hazardous Substances Data)

Usage

General Description

6-chloro-4-(ethylamino)-3-Pyridinecarboxaldehyde is a chemical compound with the molecular formula C8H9ClN2O. It is a yellow to brown powder that is commonly used in pharmaceutical research and development as an intermediate in the synthesis of various pharmaceuticals. 6-chloro-4-(ethylamino)-3-Pyridinecarboxaldehyde is also utilized as a building block in the production of agrochemicals, dyes, and other fine chemicals. It has potential applications in the pharmaceutical industry due to its ability to act as a precursor for the synthesis of various drugs and pharmaceutical compounds. Additionally, it is important to handle this chemical with care, as it may pose certain health and environmental risks if not properly managed.

Upstream product

• 959162-99-3 (6-chloro-4-(ethylamino)pyridin-3-yl)methanol 
• 959162-97-1 6-chloro-4-ethylamino-nicotinic acid ethyl ester 
• 40296-46-6 ethyl 4,6-dichloronicotinate 
• 105-50-0 diethyl 1,3-acetonedicarboxylate 
• 6975-44-6 4,6-dihydroxynicotinic acid ethyl ester 

Downstream Products

• 1012878-78-2 3-(3-amino-4-fluorophenyl)-7-chloro-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1442470-69-0 3-(5-amino-2-bromo-4-fluorophenyl)-1-ethyl-7-(2-methoxyethylamino)-1,6-naphthyridin-2(1H)-one 
• 1442470-70-3 3-(5-amino-2-chloro-4-fluorophenyl)-1-ethyl-7-(tetrahydrofuran-3-ylamino)-1,6-naphthyridin-2(1H)-one 
• 1442470-71-4 3-(5-amino-2-bromo-4-fluorophenyl)-1-ethyl-7-(2-(methylthio)ethylamino)-1,6-naphthyridin-2(1H)-one 
• 1442470-72-5 7-(4-methoxybenzylamino)-3-(5-amino-2-bromo-4-fluorophenyl)-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1442470-73-6 7-amino-3-(5-amino-2-bromo-4-fluorophenyl)-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1442470-74-7 7-(4-methoxybenzylamino)-3-(5-amino-4-fluoro-2-methylphenyl)-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1012878-90-8 7-amino-3-(5-amino-4-fluoro-2-methylphenyl)-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1442470-75-8 7-amino-3-(5-amino-2-chloro-4-fluorophenyl)-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1442470-76-9 7-(4-methoxybenzylamino)-3-(5-amino-2,4-difluorophenyl)-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1442470-43-0 7-((4-methoxybenzyl)(methyl)amino)-3-(5-amino-2-chloro-4-fluorophenyl)-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1442470-93-0 prop-1-en-2-yl (4-chloro-5-(1-ethyl-7-((4-methoxybenzyl)(methyl)amino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)carbamate 
• 1442470-98-5 prop-1-en-2-yl (4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)carbamate 
• 1442471-00-2 prop-1-en-2-yl (3-(2-chloro-4-fluoro-5-(3-phenylureido)phenyl)-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-7-yl)carbamate 

Relevant articles and documents

GEM-DISUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IDH INHIBITORS

The present invention relates to certain gem-disubstituted heterocyclic compounds, which modulate the activity of Isocitrate Dehydrogenase (IDH). The compounds of this invention are therefore useful in treating diseases caused by mutated IDH1 and/or mutat

HETEROCONDENSED PYRIDONES COMPOUNDS AND THEIR USE AS IDH INHIBITORS

The present invention relates to certain substituted heterocondensed pyridone analogues of formula (I) which modulate the activity of Isocitrate Dehydrogenase (IDH). The compounds of this invention are therefore useful in treating diseases caused by mutat

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of FGFR-4.